BMRN
Biomarin Pharmaceutical Inc
Price:  
83.51 
USD
Volume:  
2,476,410.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin WACC - Weighted Average Cost of Capital

The WACC of Biomarin Pharmaceutical Inc (BMRN) is 7.7%.

The Cost of Equity of Biomarin Pharmaceutical Inc (BMRN) is 8.00%.
The Cost of Debt of Biomarin Pharmaceutical Inc (BMRN) is 4.30%.

Range Selected
Cost of equity 6.50% - 9.50% 8.00%
Tax rate 10.60% - 36.60% 23.60%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.3% - 9.1% 7.7%
WACC

Biomarin WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.57 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 9.50%
Tax rate 10.60% 36.60%
Debt/Equity ratio 0.07 0.07
Cost of debt 4.00% 4.60%
After-tax WACC 6.3% 9.1%
Selected WACC 7.7%